CDK10 and neoplasm: CDK10 silences increases ETS2-driven transcription of c-RAF, resulting in MAPK pathway activation and loss of tumor cell reliance upon estrogen signaling [18], but to the best of our knowledge, there are still no literature reports on the roles of CDK10 in keloid pathogenesis.